Work

Phase II Trial Of Brentuximab Vedotin For CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.367.367

Authors: Madeleine Duvic, Michael Tetzlaff, Audra L Clos, Pamela Gangar, Rakhshandra Talpur

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979542832

FWCI: 5.446

Cites:

Cited by: 19

Related to: 10